Digest Network Come funziona
Network
/
Società
Fe
Non verificato

Ferring Pharmaceuticals

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

29 comunicati stampa

Guarda tutti i comunicati
12/01/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Mercato del lavoro
Industria
Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
02/12/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Oncologia
Industria
SUO and Ferring Pharmaceuticals Announce the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
26/11/2025
Analisi di mercato
Associazioni/Professionisti
Psichiatria
Salute
Vetrine/Shopping
Risorse Umane
Assistenza all'Infanzia
Farmaceutica
With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
29/10/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Industria
Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
28/10/2025
Eventi
Industria
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Salute
Oncologia
Ferring Highlights New Real-World Research with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
27/10/2025
Eventi
Industria
Scienza
Famiglia
Assistenza all'Infanzia
Medicina - Varie
Biotecnologia
Farmaceutica
Vetrine/Shopping
Salute
Ferring Pharmaceuticals Presents Two New Analyses of Pivotal Trial Data for Follitropin Delta (FE 999049) at ASRM 2025
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
27/10/2025
Scienza
HIV, AIDS e malattie autoimmuni
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Eventi
Industria
Ferring Presents New Data Analyses for REBYOTA® (fecal microbiota, live – jslm) at ACG 2025
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
20/10/2025
Igiene alimentare
Salute
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Ferring Presents New Real-World REBYOTA® (fecal microbiota, live – jslm) Data Underscoring Effectiveness and Significant Improvements in Patient Quality of Life
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
16/10/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Eventi
Industria
Ferring Expands Growing Body of Real-World Evidence Reinforcing Use of ADSTILADRIN® (nadofaragene firadenovec-vncg) in Urology Practices
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0
21/07/2025
Famiglia
Assistenza all'Infanzia
Comunicazione
Sanità
Web e Social Network
Farmaceutica
Vetrine/Shopping
Salute
Industria
Ferring Pharmaceuticals Recognizes World IVF Day by Partnering with Notable Advocates to Amplify the Conversation about Infertility
Fonte
Ferring Pharmaceuticals
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0